Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose ketamine for prevention of fentanyl-induced cough in children undergoing general anesthesia
IRCT20191128045536N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, fentanyl and Normal Saline-Benha University in cough (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pulse rate, Mean arterial pressure and 3 more. Started Apr 2020; status: completed.
02
Drugs
ketaminefentanylNormal Saline-Benha University
03
Conditions
cough
Beyond the preview
Go deeper on IRCT20191128045536N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191128045536N1.